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Objective: A novel noninvasive method for repeatedly measuring cerebral
blood flow during cardiopulmonary bypass by near-infrared spectroscopy is
described. The reproducibility of the method is investigated and a compar-
ison is made with an established technique. Methods and results: The method
is derived from the Fick principle and uses indocyanine green dye, injected
into the bypass circuit, as an intravascular tracer. Cerebral blood flow was
measured in nine children undergoing cardiopulmonary bypass on a total
of 49 occasions. Results from this study suggest that an integrating period
of 4 seconds provided a consistent measurement of global cerebral blood
flow. The values obtained ranged from 3.2 to 32.4 (median 15.9) ml z 100
gm–1 z min–1. In an additional 10 children in whom repeated measurements
were made, the coefficient of variation was 11% 6 7% (mean 6 standard
deviation). In a further study, the method was compared with microsphere
injection in five piglets undergoing cardiopulmonary bypass. The compar-
ison within each animal with the linear least squares method gave values
for R2 in the range 0.91 to 0.99. The gradients of the fits ranged from 0.5 to
1.8 (median 1.0). The mean difference between the two techniques was 5.7
ml z 100 gm–1 z min–1 or 7%. The coefficient of variation for the piglets was
14% 6 9% (mean 6 standard deviation). Conclusions: Indocyanine green
and near-infrared spectroscopy allow frequent and repeated measurements
of cerebral blood flow during cardiopulmonary bypass. The measurements
are reproducible and accurately reflect changes in cerebral blood flow. It
may be widely applicable both in research and clinical practice. (J Thorac
Cardiovasc Surg 1998;115:94-102)
Near-infrared spectroscopy (NIRS) has previouslybeen used to estimate cerebral blood flow (CBF)
from the Fick principle by observing changes in
oxyhemoglobin as an intravascular tracer in sick
newborn infants receiving intensive care,1 healthy
adults,2 and children undergoing cardiopulmonary
bypass (CPB).3 However, the use of oxyhemoglobin
makes assumptions about cerebral oxygen uptake
that may not be appropriate during CPB. This
article reports the use of an improved method that
uses the optical dye indocyanine green (ICG) as an
intravascular tracer.
Materials and methods
Theory 1: NIRS. Visible light is highly absorbed by
tissue and thus can penetrate only a few millimetres.
Near-infrared light, in the spectral range 700 to 1000 nm,
is absorbed less and can penetrate much further, up to 6
to 8 cm of brain.4 These optical properties allow trans-
mission spectroscopy to be performed in vivo.5
For linear transillumination of tissue, the modified
Beer-Lambert law can be expressed as6:
A 5 ~a@c#LB! 1 G (EQ1)
where A is the attenuation of light in optical densities;
a is the extinction coefficient of the chromophore
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(mmol21 z L z cm21); [c] is the concentration of chro-
mophore (mmol z L21); L is the distance between
points of light entry and exit (cm); B is a “pathlength
factor” that takes account of the increased optical path
caused by the scattering of light in the tissue; and G is
a factor related to tissue and optode geometry.
The attenuation caused by scattering and the geomet-
ric factor (G) is usually unknown and thus [c] cannot be
quantified absolutely. However, in a given tissue with
fixed optical geometry it is likely to remain constant in
the short term; thus changes in attenuation can be
attributed solely to changes in the concentration of
chromophore:
D@c# 5 DA/~aLB! (EQ2)
Scattering causes the distance traveled by the light to be
greater than L by a factor B, and the distance traveled is
given by the product of L and B. Provided these factors
and the extinction coefficients of the chromophores
present are known, changes in chromophore concentra-
tion can be quantified using equation 2. This study used a
value of B of 4.39 for infants less than 2 years old and 5.93
for older children.4, 7
In brain, the major endogenous chromophores that
absorb light in the spectral range 700 to 1000 nm and
whose concentrations change over the short term are
oxyhemoglobin and deoxyhemoglobin and cytochrome
oxidase.8 ICG is an exogenous chromophore that can be
administered by injection. It is a tricarbocyanine dye of
molecular weight 924.9 that absorbs near-infrared light
maximally between 795 and 805 nm. It has a low acute
toxicity with a median lethal dose (LD50) in mice of 650
mg z kg–1. The maximum recommended dose is 5
mg z kg2
1
. The dye is strongly protein bound to albumin in
plasma and rapidly and completely eliminated by the liver,
although excretion is slowed during cardiac operations.
Full pharmacologic and toxicologic data are available,9
and a product license for the use of ICG is in force in the
United States and the United Kingdom. Changes in the
concentrations of these four chromophores can be calcu-
lated from observed changes in the attenuation of light at
four wavelengths.
Theory 2: Measurement of CBF using NIRS. The Fick
principle states that the rate of accumulation of a tracer
substance in an organ (Q) is equal to the difference
between the rate of arrival and the rate of departure of
that substance. If a tracer is suddenly introduced into
the arterial blood, a measurement of the amount accu-
mulated in the organ can be made at a time (t) later.
While t is less than the minimum transit time of blood
through the organ, the tracer will not appear in the
venous efflux, and flow (f) can be measured as the ratio
of tracer accumulated to the quantity of tracer intro-
duced over the time period (t). The quantity of tracer
introduced by time t is equal to the integral of the
change in the arterial concentration of tracer at time t
(Pa[t]) with respect to time. Thus:
f 5
Q~t!
E
0
t
Pa~t!dt
(EQ3)
ICG can be injected into the CPB circuit and the concen-
tration in blood entering the aorta measured by an optical
device situated in the efferent limb of the bypass circuit.
Because no further dilution of [ICG] occurs between this
point and the brain, the concentration measured is the
cerebral arterial concentration (D[ICG]blood), and the
quantity of tracer introduced (Pa(t)) is given by the
integral of D[ICG]blood with respect to time. The increase
in ICG in the brain (D[ICG]brain) can be measured by
NIRS; this quantifies the tracer accumulation (Q(t)).
Thus:
Fig. 1. Diagram showing the disposition of equipment for measurement of cerebral blood flow. The
equipment is described in the text. ICG, Indocyanine green dye, NIRS, near-infrared spectrometer.
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CBF 5
k~D@ICG#brain!
E
0
t
@ICG#blooddt
ml z 100 gm21 z min21 (EQ4)
where k is a constant reflecting the molecular weight of
ICG, as well as tissue density and decimal conversions that
allow blood flow to be expressed per 100 gm of tissue.
Theory 3: Estimation of mean cerebral transit time.
Mean transit time (MTT) can be calculated after a rapid
injection of nondiffusable tracer by the “height over area”
method.10 The MTT is related to CBF and cerebral blood
volume (CBV) by the Stewart-Hamilton equation:
MTT 5
CBV
CBF
(EQ5)
Measurement of CBF with NIRS. Fig. 1 shows the
apparatus used to measure CBF during CPB. Near-
infrared light was carried from the NIRS spectrometer
(NIRO 500; Hamamatsu Photonics KK, Hamamatsu City,
Japan) to the head by a fiberoptic bundle (optode) placed
against the skin overlying the parietal region of the brain
at least 3.5 cm apart and held by an elastic bandage
underneath a cover to reduce background light. The light
transmitted across the head was collected by a second
optode and carried back to the spectrometer, which used
pulsed laser diodes at 4 wavelengths (776, 819, 843, and
913 nm) as light sources; changes in light attenuation were
measured every half second. The algorithm used to calcu-
late the changes in concentrations of the chromophores
incorporated a linear least squares curve fitting tech-
nique.11, 12 The extinction coefficients used in the algo-
rithm were corrected for the wavelength dependence of
pathlength using the method of Essenpreis.12 The correc-
tion factors for the wavelengths used were 0.9995, 0.9550,
0.9162, and 0.7805 (M. Cope, personal communication,
October 1994).
An optical catheter for measuring [ICG]blood (PV2024;
Pulsion Medizintechnik, Munich, Germany) was inserted
into the CPB circuit just proximal to the aorta. ICG (Pulsion
Medizintechnik, Munich, Germany), 0.1 mg z kg–1, was in-
jected into the bypass circuit and the concentration of tracer
in blood entering the body was quantified optically by a dye
densitometer (model IVH4; Pulsion Medizintechnik, Mu-
nich, Germany) to provide a measure of the arterial concen-
tration of tracer.
Study protocols. Studies were approved by the Re-
search Ethics Committees of Great Ormond Street Hos-
pital for Children (November 1991) and of Duke Univer-
sity (March 1994), and consent was obtained from the
parents of the children studied.
All animals received humane care in compliance with
the “Guide for the Care and Use of Laboratory Animals”
published by the National Institutes of Health.
Measurement of CBF and MTT in children. Nine chil-
dren undergoing CPB surgery for congenital heart disease
were studied. The diagnosis and physiologic details are
given in Table I. The pump flow was variable but was
maintained at 2.4 L z min–1 z m–2 whenever possible. CBF
and MTT were measured in all patients.
Reproducibility in children. Ten children undergoing
CPB operations for congenital heart disease were studied.
The diagnosis and physiologic details are given in Table II.
During periods of stability, groups of between three and
six CBF measurements were made. Reproducibility was
assessed by calculating the coefficient of variation and by
performing analysis of variance with child as a factor and
time as a covariate to allow for any effect of differing
pump flow and temperature.
Comparison with microspheres in an animal model.
Five newborn piglets were premedicated with ketamine (20
mg z kg–1) and acepromazine (1 mg z kg–1) and ventilated
mechanically (Sechrist infant ventilator, model IV-100B,
Sechrist Industries Inc., Anaheim, Calif.). They were then
Table I. Clinical details
Patient
Age
(mo)
Weight
(kg) Diagnosis Operation
1 6 5.6 VSD Patch closure of VSD
2 31 15.7 DORV, transposition, PS, VSD
(bidirectional Glenn at 7 mo)
TCPC
3 24 7.4 Complex DORV Intraventricular tunnel, PA reconstruction,
RV-PA conduit
4 51 13.7 TA/PS, VSD, ASD TCPC
5 147 50.0 Redo replacement of aortic prosthesis and
ileofemoral PTFE* graft
6 1 3.4 TGA Arterial switch
7 8 6.5 Tetralogy of Fallot Fallot repair
8 19 8.6 PA, large ASD, narrow aortic
arch
Glenn shunt reconstruction RPA; pulmo-
nary valve homograft
9 34 12.8 Partial AVSD Repair AVSD
ASD, Atrial septal defect; AVSD, atrioventricular septal defect; DORV, double outlet right ventricle; PA, pulmonary artery; PS, pulmonary stenosis; RPA, right
pulmonary artery; RV, right ventricle; TA, tricuspid atresia; TCPC, total cavopulmonary connection; TGA, transposition of great arteries; VSD, ventricular
septal defect.
*PTFE (polytetrafluoroethylene). A Gore-Tex vascular graft, registered trademark of W.L. Gore & Associates, Inc., Newark, Delaware.
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anesthetized with intravenous fentanyl (100 mg z kg–1
bolus and 50 mg z kg–1 per hour infusion), paralyzed
with pancuronium (0.3 mg z kg–1), and placed on CPB.
Systematically, to induce measurable changes in CBF,
pump flow and body temperature were changed. Injec-
tions of 15 mm radioactive microspheres were made at
(1) pump flow of 100 ml z kg–1 z min–1 and temperature
of 37° C; (2) 100 ml z kg–1 z min–1, 22° C; (3) 50 ml z
kg–1 z min–1, 22° C; (4) 50 ml z kg–1 z min–1, 17° C; and
(5) 25 ml z kg–1 z min–1, 17° C. Microspheres (3 3 106 in
1 ml 10% dextran and 0.01% Tween, 153Gd, 113Sn,
103Ru, 95Nb, and 46Sc in random order; NEN Research
Products, DuPont, Wilmington, Del.) were injected into
a left atrial catheter. Blood was withdrawn from the
femoral arterial catheter at a rate of 7 ml z min–1 over
120 seconds starting 10 seconds before the injection.
Measurements of CBF using ICG as a tracer were made
simultaneously with the microsphere injection as de-
scribed above; one optode was placed over the frontal
region and the other over the parietal region, both on
the right side. At each of five pump flow and tempera-
ture settings, a microsphere CBF was compared with
the mean of 3 to 7 (median 4) ICG CBF measurements.
At the end of the study the animals were killed, and the
brain was harvested. The brain was subdivided into the
cortex, basal ganglia, cerebellum, and brain stem. All the
samples were counted in a gamma counter (Minaxi Auto-
gamma Counter, 5000 Series, Packard Instrument Co.,
Meriden, Conn.), and individual nuclide activity was cal-
culated (Compusphere Microsphere Multinuclide Analy-
sis Software, Packard Instrument Co.).
The mean CBF value of the repeated NIRS measure-
ments (t 5 4 seconds) was compared with the CBF value
calculated for cortex flow by the microsphere method.
Cortex flow was chosen for comparison because it is
believed that the near-infrared technique probably re-
flects cortical flow because of the penetrance of light. The
mean, median, and range of the differences were calcu-
lated. Reproducibility was assessed from the coefficient of
variation and by performing an analysis of variance with
pig as a factor and time as a covariate.
Results
ICG CBF and MTT in children. Fig. 2 shows a
typical example of an NIRS measurement of CBF.
One to nine (median five) measurements of CBF
were made in each child, and the interval between
measurements ranged from 2.7 to 67.6 minutes,
median 13 minutes. Each measurement of CBF and
MTT took less than 10 seconds and could be
repeated within 3 minutes. Fig. 3 gives the results of
the measurements of CBF and MTT.
The effect of calculating tracer accumulation over
different periods from 2 to 6 seconds is shown in Fig.
4. Median CBF in each infant ranged from 8.0 to
67.7 (median 23.5) ml z 100 gm–1 z min–1 for calcula-
tions where t 5 2 seconds. When a greater propor-
tion of flow from longer transit time compartments
was included by increasing t to 4 seconds (see
discussion), CBF ranged from 8.2 to 32.4 (median
15.9) ml z 100 gm–1 z min–1.
Reproducibility of ICG CBF in children. One to
four (median three) groups of three to six (median
four) CBF measurements were made in each child.
For the whole group, temperature ranged from 15.9°
to 38.2° C, and pump flow ranged from 50 to 200
ml z 100 gm–1 z min–1. The time between measure-
ments within a group ranged from 0.5 to 7.4 (median
2.0) minutes. The time between groups ranged from
16.7 to 78.7 (median 30.3) minutes. The group mean
CBFs ranged from 3.2 to 70.7 (median 11.9) ml z 100
gm–1 z min–1. For the repeated measurements, the
coefficient of variation was 11% 6 7%. Analysis of
variance showed that the interindividual differences
and the effects of different pump flows and temper-
atures accounted for 73% of the variability; the
residual variability (27%) includes the reproducibil-
Table II. Clinical details
Patient
Age
(mo)
Weight
(kg) Diagnosis Operation
1 17 11.3 Tricuspid regurgitation Tricuspid valve replacement
2 5 3.9 VSD Patch closure of VSD
3 13 9.3 Tetralogy of Fallot Fallot repair
4 149 46 Aortic incompetence Aortic valve replacement
5 4 4.9 Tetralogy of Fallot Fallot repair
6 55 18.5 AVSD Patch of ASD
7 35 12.5 Truncus arteriosus Truncus repair
8 36 12.9 ASD Closure of ASD
9 49 15.5 Complex heart, PA Fontan
10 2 4.6 VSD VSD closure
ASD, Atrial septal defect; AVSD, atrioventricular septal defect; PA, pulmonary atresia; VSD, ventricular septal defect.
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ity of the technique and any other factors not
measured.
Comparison with microspheres in piglets. In
three pigs, five measurements of CBF were made
using radiolabeled microspheres; two pigs had
four measurements. The relation between the two
methods is shown in Fig. 5. The fit within each
animal as estimated by R2 was good (R2 range 0.91
to 0.99). The gradient of the fits ranged from 0.5
to 1.8 (median 1.0). The mean difference was 5.7
ml z 100 gm–1 z min–1 (median 7.1, range –30.1 to
21.9).
The coefficient of variation was 14% 6 9%.
Analysis of variance showed that the effects of
interindividual variation, temperature, and pump
flow accounted for 84% of the variability.
Discussion
Accuracy of NIRS. Precise determination of
changes in [ICG] requires (1) accurate data for the
absorption spectra of all mobile chromophores
present; (2) that the modified Beer-Lambert rela-
tionship is valid; (3) that the scattering properties of
the tissue under interrogation are known so that the
differential pathlength factor (DPF) for transport of
light can be estimated accurately; and (4) that there
is accurate analysis of absorption changes. These
will be considered in turn.
Near-infrared spectra for hemoglobin and cyto-
chrome oxidase have been measured under carefully
controlled conditions by several groups.13-15 Spectra
measured in vivo and in vitro are identical and
confirmed that the brain normally contains only
three mobile chromophores.8, 11 Because the exog-
enous tracer molecule ICG is strongly protein-
bound in vivo, we have now measured absorption
spectra for ICG in the presence of plasma protein
(see Appendix Table I).
The validity of the modified Beer-Lambert law in
biologic tissue has been demonstrated both by the-
oretical modeling and experimental measurement.6
Fig. 2. Experimental record showing the effect of a injec-
tion of ICG, 0.1 mg kg21, on blood (lower trace) and brain
(upper trace) ICG concentrations.
Fig. 3. Values for cerebral blood flow and mean transit
time obtained in nine infants during CPB operation. Each
infant is represented by a different symbol.
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The scattering properties of adult brain in vivo
and postmortem neonatal brain have been mea-
sured, and the extinction coefficients used in the
conversion algorithm are corrected for the mea-
sured variation in the scattering of light by cerebral
tissue at different wavelengths.4 We have used the
DPF measured in infants for children up to 2 years
of age and for adults above that age based on an
estimation of the amount of myelin in the develop-
ing brain. This will introduce some inaccuracy into
our results that will be corrected in the future when
routine measurements of the pathlength of light
become available. Technology has recently been
developed that will allow pathlength to be measured
routinely by phase modulation during all NIRS
procedures.16
Measurements of changes in the attenuation of
light at four wavelengths were analyzed using a
linear least squares technique. Other workers
have demonstrated that the errors induced by
using this technique are very small.17 System noise
and systematic error are a small fraction of the
total signal.18
Measurement of CBF by NIRS. The use of ICG
as an intravascular tracer rests on several assump-
tions. It is assumed (1) that the tracer is not
consumed by the organ, (2) that the flow to the
organ remains constant, (3) that the total volume
of blood in the organ remains constant, (4) that
Fig. 4. Graph relating values for CBF to the integration
period t in 49 measurements in nine infants. Inhomoge-
neity of flow is demonstrated, with shorter integration
periods leading to higher measured values in some infants.
Fig. 5. Graphs showing the relation between CBF mea-
sured by the ICG method and cortical flow measured with
microspheres for each animal.
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there is no further admixture of blood beyond the
point of [ICG]blood measurement in the bypass
circuit, and (5) that the measurement is made
over a time period less than the minimum transit
time of the tracer through the organ. These will be
addressed in turn.
ICG is an inert substance that is not consumed by
the brain.
The assumption of constant blood flow is required
for all methods of CBF measurement, but it poses
less of a problem for the present method, where a
measurement requires only 4 to 6 seconds, than for
conventional methods such as the Kety-Schmidt
technique, or measurements of 133Xe clearance,
which assume constant flow for 10 minutes or more,
a condition unlikely to be met during CPB.
Constant CBV is also assumed by other measure-
ment techniques. NIRS measures changes in total
cerebral hemoglobin concentration, which is directly
related to CBV. Thus any change in CBV during
measurement of CBF can be observed and the
measurement disregarded. This is not possible with
other methods for estimation of CBF.
Any admixture of blood beyond the point of
[ICG]blood measurement would cause CBF to be
underestimated. However, this is extremely unlikely
to occur given the placement of the efferent catheter
from the pump-oxygenator.
CBF measurements should be completed in less
than the minimum transit time of blood through the
organ for quantification of the total amount of
tracer accumulated. Although minimum transit time
was not measured in our subjects, values obtained
for MTT were much higher than the chosen values
for t, suggesting that only trivial volumes of blood
would have passed through the brain in less than the
measurement period.
Inhomogeneity of CBF. The period of integration
t is chosen with respect to the distribution of transit
times within the organ and should be explicit be-
cause any specific t weights the measured value to a
particular distribution of blood flow.19 Low values
for t will measure the flow of blood that passes
through the brain with a short transit time, whereas
higher values for t will include components of total
CBF with longer transit times. Comparison of values
for CBF calculated for values of t between 2 and 6
seconds1, 2 revealed predictable inhomogeneity of
flow within the brain (Fig. 4).
CBFs calculated over shorter periods were gener-
ally higher than flow compartments of longer transit
time. The value of CBF obtained will thus be
modulated by the value chosen for t. Measurements
that use fewer points on the tracer accumulation
curve have larger variability,19 and studies of adult
volunteers using oxyhemoglobin as a tracer,19 as well
as inspection of Fig. 4, suggest that integration more
than 4 seconds provides a stable and consistent
measurement of global CBF.
Cerebral blood flow and MTT. Measurement of
CBF requires only the first few seconds of tracer
accumulation, but if the full period of tracer passage
through the brain is observed, MTT can be calculated
by conventional methods.20 The inverse relation be-
tween CBF and MTT predicted by the Stewart-Ham-
ilton equation was found and is shown in Fig. 3.
Comparison studies. The coefficient of variation
for the studies in children and in piglets were
comparable with values for other methods of mea-
suring CBF. The fit within each piglet as estimated
by R2 is good. However, the slopes of the fits are
variable. It is known from measurements in human
beings that the DPF varies considerably between
subjects.4, 16 However, to account for all the varia-
tion in slope found here, a standard deviation of
50% of the mean DPF would be required. The R2
for each animal implies good agreement on change
for percentage flow change between the two meth-
ods across a wide range of temperature and pump
flow values. This would suggest that for one subject
the DPF value remains constant across the range of
CPB conditions even though it may be subject to
intersubject variation.
Technical difficulties and assumptions exist for all
CBF techniques, including those using micro-
spheres, and these may become even more impor-
tant during CPB. The microsphere technique mea-
sures regional CBF as the NIRS method is also
considered to do. An inherent variability exists in
both the microsphere technique (of 10% to 20%)
and in the NIRS method that may account for some
of the discrepancy between them. In addition, the
NIRS technique may interrogate a variable contri-
bution from tissues not accounted for in any of the
microsphere measurements, such as skull and skin.
Clinical value of CBF measurements during CPB.
A significant number of children and adults who
undergo CPB operations survive with neurodevel-
opmental or intellectual impairment, probably
caused by perioperative derangements of CBF.21
The method described here should allow multiple
measurements of CBF to be made during a single
operating session and permit CBF, as well as other
variables such as CBV, MTT, cerebral oxygen, and
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glucose delivery, to be routinely measured. It may be
possible to define critical levels of CBF that should
trigger appropriate responses from physicians caring
for patients during surgery to prevent ischemic
injury from occurring.
Future developments. The technique detailed
here requires validation, perhaps comparing with
the Kety-Schmidt technique, under the special con-
ditions of CPB surgery, both in children and in adult
patients. Improvements in the accuracy of the tech-
nique can be expected as NIRS technology im-
proves, for example with the introduction of contin-
uous measurement of the optical pathlength.22 Use
of NIRS allows the acquisition of other data on
cerebral oxygenation simultaneously during CBF
measurements,3 and there is also the prospect of
regional flow estimations when NIRS localization
becomes available.23
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Appendix Table I. Specific extinction coefficients of indocyanine green in 1% bovine serum albumin solution.
Wavelength
(nm)
ICG
(mmol 21 z L z cm21)
Wavelength
(nm)
ICG
(mmol 21 z L z cm21)
Wavelength
(nm)
ICG
(mmol 21 z L z cm21)
750 87.749 808 161.148 866 7.719
752 89.299 810 155.574 868 7.202
754 90.373 812 148.850 870 6.877
756 91.468 814 141.097 872 6.376
758 92.836 816 132.440 874 6.131
760 94.485 818 123.420 876 5.902
762 96.705 820 114.057 878 5.709
764 99.322 822 104.226 880 5.363
766 102.342 824 94.242 882 5.169
768 105.755 826 85.140 884 5.148
770 109.317 828 75.993 886 4.986
772 113.466 830 67.463 888 4.781
774 117.926 832 59.916 890 4.569
776 122.538 834 52.489 892 4.427
778 127.457 836 45.876 894 4.422
780 132.638 838 40.023 896 4.332
782 137.606 840 34.921 898 4.296
784 142.903 842 30.298 900 4.076
786 148.113 844 26.466 902 4.034
788 153.212 846 23.030 904 4.073
790 157.682 848 20.107 906 4.060
792 161.981 850 17.575 908 4.041
794 165.409 852 15.477 910 3.957
796 168.067 854 13.624 912 3.892
798 169.906 856 12.239 914 4.084
800 170.695 858 10.991 916 4.040
802 170.149 860 9.858 918 4.191
804 168.306 862 9.006 920 4.287
806 165.387 864 8.322 922 4.293
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